Goldman Sachs Reiterates Buy Rating on HCA Healthcare, Inc. (HCA)
Rating Change Goldman Sachs analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on July 28, 2026. Market Context HCA Healthcare, Inc.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Goldman Sachs analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on July 28, 2026. Market Context HCA Healthcare, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Constellation Energy Corporation (NASDAQ:CEG) on July 28, 2026. Market Context Constellation Energy Corporation…
Read moreRating Change UBS analysts reiterated a Buy rating on Constellation Energy Corporation (NASDAQ:CEG) on July 28, 2026. Market Context Constellation Energy Corporation operates in…
Read moreRating Change UBS analysts upgraded Medtronic plc (NYSE:MDT) from Neutral to Buy on July 28, 2026. Market Context Medtronic plc operates in the Healthcare sector. The stock…
Read moreRating Change Loop Capital analysts initiated coverage on CrowdStrike Holdings, Inc. Class A Common Stock (NASDAQ:CRWD) with a Buy rating on July 28, 2026. Market Context…
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Capital One Financial Corporation (NYSE:COF) on July 28, 2026. Market Context Capital One Financial…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Capital One Financial Corporation (NYSE:COF) on July 28, 2026. Market Context Capital One Financial Corporation…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Intel Corporation (NASDAQ:INTC) on July 28, 2026. Market Context Intel Corporation operates in the Technology…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Uber Technologies, Inc. (NYSE:UBER) on July 28, 2026. Market Context Uber Technologies, Inc.
Read moreRating Change TD Cowen analysts downgraded Intuit Inc. (NASDAQ:INTU) from Buy to Hold on July 28, 2026. Market Context Intuit Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Abbott Laboratories (NYSE:ABT) on July 28, 2026. Market Context Abbott Laboratories operates in the Healthcare sector. The…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Chevron Corporation (NYSE:CVX) on July 28, 2026. Market Context Chevron Corporation operates in the Energy…
Read moreRating Change B of A Securities analysts downgraded Exxon Mobil Corporation (NYSE:XOM) from Buy to Neutral on July 28, 2026. Market Context Exxon Mobil Corporation operates in the…
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Meta Platforms, Inc. (NASDAQ:META) on July 28, 2026. Market Context Meta Platforms, Inc.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 28, 2026. Market Context Amazon.com, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 28, 2026. Market Context Amazon.com, Inc.
Read moreRating Change BMO Capital analysts reiterated a Outperform rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 28, 2026. Market Context Amazon.com, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Microsoft Corporation (NASDAQ:MSFT) on July 28, 2026. Market Context Microsoft Corporation operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on NeuroPace, Inc. (NASDAQ:NPCE) on July 29, 2026.
Read moreRating Change Needham analysts reiterated a Buy rating on Itron, Inc. (NASDAQ:ITRI) on July 29, 2026. Market Context Itron, Inc.
Read more